share_log

Plus Therapeutics(PSTV.US):2024年Q1财报实现营收167.7万美元,前值为50.6万美元,预期值为169万美元;每股收益为-0.75美元,前值为-2.07美元,预期值为-1.09美元。

Plus Therapeutics (PSTV.US): The 2024 Q1 financial report achieved revenue of US$1.677 million, with a previous value of US$506,000 and an expected value of US$1.69 million; earnings per share were -0.75 dollars, previous value was -2.07 US dollars, and e

Zhitong Finance ·  May 16 04:40
Plus Therapeutics (PSTV.US): The 2024 Q1 financial report achieved revenue of US$1.677 million, with a previous value of US$506,000 and an expected value of US$1.69 million; earnings per share were -0.75 dollars, previous value was -2.07 US dollars, and expected value was -1.09 US dollars.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment